RA PHARMACEUTICALS, INC. Operating Cash Flow
RA PHARMACEUTICALS, INC. reported Operating Cash Flow of -$87.36 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$28.61M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$22.36M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-06-30 was -$18.37M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-03-31 was -$18.02M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$87.36M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$54.95M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2017 was -$46.78M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2016 was -$21.84M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$28.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$50.97M derived: sum of 2 quarters · filed 2020-02-27 | -$69.34M derived: sum of 3 quarters · filed 2020-02-27 | -$87.36M 10-K · filed 2020-02-27 |
| 2019-09-30 | -$22.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$40.73M derived: sum of 2 quarters · filed 2019-11-07 | -$58.75M 10-Q · filed 2019-11-07 | -$70.82M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | -$18.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$36.39M 10-Q · filed 2019-08-07 | -$48.46M derived: sum of 3 quarters · filed 2020-02-27 | -$62.29M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | -$18.02M 10-Q · filed 2019-05-09 | -$30.10M derived: sum of 2 quarters · filed 2020-02-27 | -$43.92M derived: sum of 3 quarters · filed 2020-02-27 | -$57.45M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | -$12.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$25.90M derived: sum of 2 quarters · filed 2020-02-27 | -$39.43M derived: sum of 3 quarters · filed 2020-02-27 | -$54.95M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$13.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$27.36M derived: sum of 2 quarters · filed 2019-11-07 | -$42.87M 10-Q · filed 2019-11-07 | -$56.52M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$13.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$29.04M 10-Q · filed 2019-08-07 | -$42.69M derived: sum of 3 quarters · filed 2019-08-07 | -$54.91M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$15.52M 10-Q · filed 2019-05-09 | -$29.17M derived: sum of 2 quarters · filed 2019-05-09 | -$41.38M derived: sum of 3 quarters · filed 2019-05-09 | -$50.30M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$13.65M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$25.86M derived: sum of 2 quarters · filed 2019-03-07 | -$34.78M derived: sum of 3 quarters · filed 2019-03-07 | -$46.78M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$12.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$21.13M derived: sum of 2 quarters · filed 2018-11-07 | -$33.13M 10-Q · filed 2018-11-07 | -$42.15M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | -$8.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$20.91M 10-Q · filed 2018-08-08 | -$29.94M derived: sum of 3 quarters · filed 2018-08-08 | -$37.43M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$12.00M 10-Q · filed 2018-05-09 | -$21.02M derived: sum of 2 quarters · filed 2018-05-09 | -$28.52M derived: sum of 3 quarters · filed 2018-05-09 | |
| 2016-12-31 | -$9.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$16.52M derived: sum of 2 quarters · filed 2018-03-14 | -$21.84M 10-K · filed 2018-03-14 | |
| 2016-09-30 | -$7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$12.82M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$5.32M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$12.02M 10-K · filed 2018-03-14 |